Table III.
The activity of the combination of cloxacillin and thioridazine against Staphylococcus aureus strains in vitro.
Strain | FICI |
---|---|
MRSA14 | 0.38 |
MRSA15 | 0.63 |
MRSA16 | 0.75 |
MRSA20 | 0.25 |
MRSA21 | 0.50 |
MRSA22 | 0.63 |
MRSA25 | 0.31 |
MRSA29 | 0.19 |
MRSA30 | 1.06 |
MRSA64 | 0.25 |
MRSA65 | 0.25 |
MRSA75 | 1.13 |
MRSA76 | 1.13 |
MRSA92 | 0.31 |
MRSA94 | 0.19 |
MRSA97 | 0.25 |
MRSA98 | 0.19 |
MRSA125 | 0.27 |
MRSA126 | 0.50 |
MRSA134 | 0.16 |
MRSA135 | 0.16 |
MRSA142 | 0.63 |
MRSA162 | 0.38 |
ATCC 29213 | 0.28 |
MSSA10 | 0.31 |
MSSA13 | 0.56 |
MSSA14 | 0.63 |
MSSA31 | 0.63 |
MSSA36 | 0.38 |
MSSA41 | 0.63 |
MSSA42 | 0.56 |
MSSA44 | 0.38 |
MSSA50 | 0.38 |
MSSA51 | 0.14 |
MSSA54 | 0.38 |
MSSA56 | 0.63 |
MSSA62 | 0.63 |
MSSA65 | 0.63 |
MSSA66 | 1.13 |
MSSA67 | 1.13 |
MSSA68 | 1.13 |
MSSA70 | 1.13 |
MSSA72 | 1.06 |
MSSA73 | 0.63 |
MSSA78 | 1.25 |
MSSA79 | 1.25 |
MSSA80 | 0.25 |
See FICI criteria for details.